Biological SBS30 occurs more rarely: it is caused by loss-of-function in glycosylases in BER due to biallelic inactivation mutations in NTHL1, and patients carrying this variant are with an increased lifetime risk for CRC, breast cancer, and colorectal polyposis27,28,35. Here, NTHL1 is linked to colorectal carcinoma.